[8-K] Renovaro Inc. Reports Material Event

Rhea-AI Filing Summary

Renovaro Inc. (Nasdaq: RENB) filed an 8-K reporting the forthcoming resignation of Chairman Maurice van Tilburg. The Board was notified on 22 Jul 2025, and the resignation becomes effective 22 Aug 2025. The filing states the departure is driven by Mr. van Tilburg’s acceptance of a leadership role at an unrelated company and is not due to any disagreement with Renovaro regarding operations, policies, or practices.

The change is disclosed under Item 5.02 and no successor has yet been named. CEO David Weinstein signed the filing. While the orderly, conflict-free exit limits governance risk, the loss of an experienced board leader may create short-term uncertainty until a replacement is announced. Investors should watch for updates on board succession and any impact on strategic oversight.

Insights

Corporate Governance Expert

TL;DR: Chairman exit is orderly but removes key oversight; modest negative governance signal.

Board-level turnover is always material. The clean explanation—career move, no disagreements—mitigates concerns of internal strife, yet investors lose an experienced chair who guided strategy and shareholder relations. Absence of a named successor suggests interim governance gap. Unless quickly filled by a qualified independent director, ISS and Glass Lewis could flag the vacancy, potentially influencing proxy votes. Overall impact: slightly negative but manageable.

Portfolio Manager

TL;DR: Neutral-to-slightly negative; monitor succession plan before adjusting position.

Chairman departures rarely move revenue or cash flow, so near-term financial models stay intact. However, board continuity affects strategic execution, especially for small-cap biotech firms like RENB. Absent a successor, I’d apply a modest governance discount to valuation multiples until clarity emerges. No disagreement language keeps risk contained; therefore I am not altering core holdings but will track follow-up disclosures.

false 0001527728 0001527728 2025-07-25 2025-07-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 25, 2025

RENOVARO INC.

(Exact name of registrant as specified in its charter)

Delaware		001-38751		45-2259340
(State or other jurisdiction		(Commission File Number)		(I.R.S. Employer
of incorporation)				Identification No.)

2080 Century Park East, Suite 906

Los Angeles, CA 90067

 (Address of principal executive offices)

+1 (305) 918-1980

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class		Trading Symbol		Name of Each Exchange on Which Registered
Common Stock, par value $0.0001 per share		RENB		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On July 22, 2025, Maurice van Tilburg, Chairman of the Board of Directors notified the Board of Directors of Renovaro Inc. of his resignation as Chairman of the Board, effective August 22, 2025.

Mr. Tilburg’s resignation was not the result of any disagreement with the Company on any matter relating to its operations, policies, or practices. The resignation is due to his recent acceptance of a leadership position at another company in an unrelated sector, which will limit his availability to dedicate sufficient time to the Company.

The Board of Directors and management thank Mr. Tilburg for his dedicated service and leadership during his tenure and wish him continued success in his future endeavors.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	RENOVARO INC.
	By:	/s/ David Weinstein
		Name: David Weinstein Title: Chief Executive Officer

Date: July 25, 2025

FAQ

Why did Renovaro (RENB) Chairman Maurice van Tilburg resign?

He accepted a leadership role at an unrelated company, limiting his availability to serve Renovaro.

When will the resignation of Maurice van Tilburg be effective?

22 August 2025.

Did the resignation involve any disagreement with Renovaro?

No. The 8-K states there was no disagreement regarding operations, policies, or practices.

Who signed the July 25 2025 8-K for Renovaro Inc.?

Chief Executive Officer David Weinstein.

What exchange does Renovaro’s stock trade on and under what symbol?

The Nasdaq Stock Market LLC under the symbol RENB.

Is Renovaro Inc. considered an emerging growth company?

No. The filing’s checkbox for emerging growth company is unchecked.